152 related articles for article (PubMed ID: 37691472)
1. De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?
Brignola C; Volorio S; De Vecchi G; Zaffaroni D; Dall'Olio V; Mariette F; Sardella D; Capra F; Signoroni S; Rausa E; Vitellaro M; Pensotti V; Ricci MT
Tumori; 2024 Feb; 110(1):69-73. PubMed ID: 37691472
[TBL] [Abstract][Full Text] [Related]
2. A de novo pathogenic variant in the MSH6 gene in a 52 years-old woman.
Pierre-Noël E; Airaud F; Cauchin E; Garrec C; Ricordeau I; Michon C; Kerdraon O; Bezieau S; Abadie C
Fam Cancer; 2022 Jul; 21(3):319-324. PubMed ID: 34519923
[TBL] [Abstract][Full Text] [Related]
3. Molecular tumor testing in patients with Lynch-like syndrome reveals a de novo mosaic variant of a mismatch repair gene transmitted to offspring.
Guillerm E; Svrcek M; Bardier-Dupas A; Basset N; Coulet F; Colas C
Eur J Hum Genet; 2020 Nov; 28(11):1624-1628. PubMed ID: 32678338
[TBL] [Abstract][Full Text] [Related]
4. Somatic mosaicism by a de novo MLH1 mutation as a cause of Lynch syndrome.
Geurts-Giele WR; Rosenberg EH; Rens AV; Leerdam MEV; Dinjens WN; Bleeker FE
Mol Genet Genomic Med; 2019 Jul; 7(7):e00699. PubMed ID: 31104363
[TBL] [Abstract][Full Text] [Related]
5. De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.
Goel A; Nguyen TP; Leung HC; Nagasaka T; Rhees J; Hotchkiss E; Arnold M; Banerji P; Koi M; Kwok CT; Packham D; Lipton L; Boland CR; Ward RL; Hitchins MP
Int J Cancer; 2011 Feb; 128(4):869-78. PubMed ID: 20473912
[TBL] [Abstract][Full Text] [Related]
6. MLH1 epimutation is a rare mechanism for Lynch syndrome: A case report and review of the literature.
Zyla R; Graham T; Aronson M; Velsher L; Mrkonjic M; Turashvili G
Genes Chromosomes Cancer; 2021 Sep; 60(9):635-639. PubMed ID: 33934415
[TBL] [Abstract][Full Text] [Related]
7. A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case report.
Walker R; Clendenning M; Joo JE; Xue J; Mahmood K; Georgeson P; Como J; Joseland S; Preston SG; Chan JM; Jenkins MA; Rosty C; Macrae FA; Di Palma S; Campbell A; Winship IM; Buchanan DD
Fam Cancer; 2023 Oct; 22(4):423-428. PubMed ID: 37318702
[TBL] [Abstract][Full Text] [Related]
8. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
9. Integrating Tumor Sequencing Into Clinical Practice for Patients With Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers.
Dixon K; Asrat MJ; Bedard AC; Binnington K; Compton K; Cremin C; Heidary N; Lohn Z; Lovick N; McCullum M; Mindlin A; O'Loughlin M; Petersen T; Portigal-Todd C; Scott J; St-Martin G; Thompson J; Turnbull R; Mung SW; Hong Q; Bezeau M; Bosdet I; Tucker T; Young S; Yip S; Aubertin G; Blood KA; Nuk J; Sun S; Schrader KA
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00397. PubMed ID: 34397043
[TBL] [Abstract][Full Text] [Related]
10. Identification of Lynch Syndrome.
Maratt JK; Stoffel E
Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):45-58. PubMed ID: 34798986
[TBL] [Abstract][Full Text] [Related]
11. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.
Hitchins MP
Fam Cancer; 2016 Jul; 15(3):413-22. PubMed ID: 26886015
[TBL] [Abstract][Full Text] [Related]
12. Implication of DNA repair genes in Lynch-like syndrome.
Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X
Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425
[TBL] [Abstract][Full Text] [Related]
13. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing].
Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589
[No Abstract] [Full Text] [Related]
14. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
[TBL] [Abstract][Full Text] [Related]
15. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family.
Yang C; Sheehan M; Borras E; Cadoo K; Offit K; Zhang L
Fam Cancer; 2020 Oct; 19(4):315-322. PubMed ID: 32356167
[TBL] [Abstract][Full Text] [Related]
17. Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation.
Pinto D; Pinto C; Guerra J; Pinheiro M; Santos R; Vedeld HM; Yohannes Z; Peixoto A; Santos C; Pinto P; Lopes P; Lothe R; Lind GE; Henrique R; Teixeira MR
Cancer Med; 2018 Feb; 7(2):433-444. PubMed ID: 29341452
[TBL] [Abstract][Full Text] [Related]
18. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.
Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K
Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297
[TBL] [Abstract][Full Text] [Related]
19. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers.
Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ
J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216
[TBL] [Abstract][Full Text] [Related]
20. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
